FDA Inspection 1047936 — Seock-Ah Im, MD, PhD

Seock-Ah Im, MD, PhD — FEI 3009399572

The FDA completed an inspection of Seock-Ah Im, MD, PhD on Mar 29, 2018 in Seoul. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 29, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Seoul (Korea (the Republic of))

Additional Details

Clinical Investigator (CI)